DK363887D0 - Anvendelse af bromcruptin - Google Patents

Anvendelse af bromcruptin

Info

Publication number
DK363887D0
DK363887D0 DK363887A DK363887A DK363887D0 DK 363887 D0 DK363887 D0 DK 363887D0 DK 363887 A DK363887 A DK 363887A DK 363887 A DK363887 A DK 363887A DK 363887 D0 DK363887 D0 DK 363887D0
Authority
DK
Denmark
Prior art keywords
bromcruptin
Prior art date
Application number
DK363887A
Other languages
English (en)
Other versions
DK363887A (da
Inventor
Douglas Larson
Peter Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK363887D0 publication Critical patent/DK363887D0/da
Publication of DK363887A publication Critical patent/DK363887A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK363887A 1986-07-14 1987-07-13 Anvendelse af bromcruptin DK363887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
DK363887D0 true DK363887D0 (da) 1987-07-13
DK363887A DK363887A (da) 1988-01-15

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK363887A DK363887A (da) 1986-07-14 1987-07-13 Anvendelse af bromcruptin

Country Status (13)

Country Link
JP (1) JPS6323817A (da)
KR (1) KR880001292A (da)
AU (1) AU602154B2 (da)
CH (1) CH672987A5 (da)
DE (1) DE3722383A1 (da)
DK (1) DK363887A (da)
FR (1) FR2601245A1 (da)
GB (1) GB2192541B (da)
IT (1) IT1224222B (da)
NL (1) NL8701631A (da)
PH (1) PH24525A (da)
SE (1) SE8702843L (da)
ZA (1) ZA875145B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten
EP0327040A3 (de) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5716932A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
CZ282909B6 (cs) * 1991-12-23 1997-11-12 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Použití agonisty dopaminu a stimulátoru prolaktinu pro přípravu farmaceutického přípravku a tento farmaceutický přípravek
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
DK2091537T3 (da) 2006-11-23 2013-08-26 Sinoxa Pharma Gmbh Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati
ES2897475T3 (es) * 2016-04-20 2022-03-01 Veroscience Llc Composición y método para el tratamiento de trastornos metabólicos
EP3697418A4 (en) 2017-10-18 2021-07-14 VeroScience LLC IMPROVED BROMOCRIPTIN FORMULATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.

Also Published As

Publication number Publication date
IT1224222B (it) 1990-09-26
SE8702843L (sv) 1988-01-15
DE3722383A1 (de) 1988-01-28
JPS6323817A (ja) 1988-02-01
AU7558787A (en) 1988-01-21
GB2192541A (en) 1988-01-20
DK363887A (da) 1988-01-15
PH24525A (en) 1990-07-18
IT8748160A0 (it) 1987-07-10
CH672987A5 (da) 1990-01-31
ZA875145B (en) 1989-02-22
NL8701631A (nl) 1988-02-01
AU602154B2 (en) 1990-10-04
KR880001292A (ko) 1988-04-22
GB2192541B (en) 1990-05-02
FR2601245A1 (fr) 1988-01-15
GB8716323D0 (en) 1987-08-19
SE8702843D0 (sv) 1987-07-13

Similar Documents

Publication Publication Date Title
DK208188D0 (da) Anvendelse af 17-ketosteroider
DK363887A (da) Anvendelse af bromcruptin
DK193588D0 (da) Anvendelser af dopaminagonister
DK662687A (da) Anvendelse af tricycliske carbazoloner
DK185988A (da) Anvendelse af antigen
DK38593A (da) Alkoxymethylethere af glyceroler
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK120389A (da) Anvendelse af progestin
DK102389A (da) Anvendelse af interleukin
DK104389A (da) Anvendelse af imidazolderivater
DK564886D0 (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
DK293787A (da) Ekspression af en amyloglucosidase
DK541487A (da) Sammenfoejning af materialer
DK289987A (da) Anvendelse af avaron- og avarolderivater
DK309888D0 (da) Fremstilling af glyceraldehyd-3-phosphat-dehydrogenase
DK237385A (da) Anvendelse af dihydroergotamin
DK185987D0 (da) Anvendelse af prostaglandiner
DK289887A (da) Anvendelse af avaron- og avarolderivater
DK135387D0 (da) Fremstilling af proteiner
DK153045C (da) Sammenkobling af fortrinsvis langstrakte elementer
DK333587A (da) Anvendelse af pyridinderivater
ES296589Y (es) Conjunto parcial de peluca
SE8603968D0 (sv) New use
DK0402857T3 (da) Anvendelse af 17beta-cyclopropylamino-androsten-derivater
DK171389D0 (da) Anvendelse af acetazolamid

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment